JSA advised Tata Capital Health Care Fund II, (“TCHF II”) in its investment in Mumbai-based dialysis chain Apex Kidney Care (“AKC”). The transaction was a mix of primary and secondary investment.
TCHF II is a growth-oriented private equity fund focused on the healthcare and life sciences sector in India. TCHF II is sponsored by Tata Capital Ltd.
AKC with over 180 dialysis centres, will utilise the newly infused capital to expand its dialysis network to 300 centres pan-India in next 18-24 months, of which about 50-60 dialysis centres will be standalone centres.
Our Transaction Team Comprised Lead Partner – Lalit Kumar, Partner – Bharati Joshi, Principal Associate – Amandeep Singh Virk and Associate – Harshita Agarwal and Zarish Ali.
Our Employment Team Comprised Partner – Minu Dwivedi.
Our Tax Team Comprised Partner – Kumarmanglam Vijay and Surajkumar Shetty.